Streetbeat News

Analyst Ratings

ATR

BWA

DEA

ESTC

S

Several Wall Street analysts have upgraded their ratings for key stocks, including Elastic N.V., SentinelOne, AptarGroup, BorgWarner, and Easterly Government Properties. These upgrades could influence short-term stock movements.

Portfolio Pulse from Avi Kapoor

October 14, 2024 | 1:10 pm

WFC

Evercore ISI Group has maintained an 'Outperform' rating on Wells Fargo and raised its price target from $68 to $71, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 1:10 pm

TPG

Evercore ISI Group analyst Glenn Schorr has maintained an 'In-Line' rating for TPG (NASDAQ:TPG) and raised the price target from $46 to $60.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 1:08 pm

STEP

Evercore ISI Group has maintained an 'Outperform' rating on StepStone Group and raised the price target from $52 to $55, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 1:07 pm

ESI

Seaport Global has initiated coverage on Element Solutions (NYSE:ESI) with a Buy rating and set a price target of $33.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 1:06 pm

PSA

Evercore ISI Group has maintained an 'In-Line' rating for Public Storage (NYSE:PSA) but has lowered its price target from $343 to $338.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 1:05 pm

TKR

Citigroup analyst Kyle Menges has initiated coverage on Timken (NYSE:TKR) with a Neutral rating and set a price target of $90.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 1:04 pm

MBLY

Evercore ISI Group has maintained an 'Outperform' rating on Mobileye Global but has lowered the price target from $35 to $30.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 1:03 pm

KKR

Evercore ISI Group has maintained an 'Outperform' rating on KKR and raised its price target from $135 to $145, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 1:02 pm

NRIX

Stephens & Co. analyst Sudan Loganathan has reiterated an Overweight rating on Nurix Therapeutics (NASDAQ:NRIX) and maintained a $31 price target.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 1:02 pm